Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › DNA aptamers specific to CD2000R1 and their therapeutic uses

DNA aptamers specific to CD2000R1 and their therapeutic uses

US Patent 10584342 · Granted Mar 10, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the2024
Devices and methods for wound-conformal guidance of bioprinter printhead2024
DNA aptamers specific to CD200R1 and their therapeutic uses2018
DNA aptamers specific to CD200R1 and their therapeutic uses2018
DNA aptamers specific to CD200R1 and their therapeutic uses2018
N-domain of carcinoembryonic antigen and compositions, methods and uses thereof2017
N-domain of carcinoembryonic antigen and compositions, methods and uses thereof2014
Assay for soluble CD2002012
Methods of treating cancer by administering antibodies to CD2002012
Aptamers directed to MUC12011
Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally 2011
Methods and compositions for modulating immunity2011